Clinical trial
Sleep, Aging and Risk for Alzheimer's Disease (SARA) Study
NCT01962779 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sleep, Aging and Risk for Alzheimer's Disease (SARA) Study
- Lead sponsor
- NYU Langone Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- May 3, 2017
- Enrollment
- 235 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease, sleep disordered breathing